In contrast, m6A levels in the peripheral blood of individuals with Type 2 diabetes mellitus (T2DM) are lower than in controls, with concomitantly high m6A ‘eraser’ FTO gene expression [147]. The gene discussed is FTO; the disease is type 2 diabetes mellitus.